Topical Timolol: a Comparison of Surgical Outcomes
NCT05114239
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Wound Heal
Interventions
DRUG:
Timolol 0.25% Ophthalmic Solution
OTHER:
Standard Wound Care
Sponsor
Keith G. LeBlanc, Jr, MD